4//SEC Filing
Viehbacher Christopher 4
Accession 0001127602-22-026909
CIK 0000875045other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:11 PM ET
Size
10.3 KB
Accession
0001127602-22-026909
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Viehbacher Christopher
DirectorPresident and CEO
Transactions
- Award
Performance Stock Unit
2022-12-01+45,998→ 45,998 total→ Common Stock (45,998 underlying) - Award
Stock Option
2022-12-01+80,522→ 80,522 totalExercise: $301.85Exp: 2032-12-01→ Common Stock (80,522 underlying) - Award
Restricted Stock Unit
2022-12-01+7,040→ 7,040 total→ Common Stock (7,040 underlying)
Footnotes (4)
- [F1]The Stock Options are eligible to vest and become exercisable in approximately equal annual installments on the first, second and third anniversaries of the grant date of December 1, 2022.
- [F2]Each Performance Stock Unit ("PSU") or Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock.
- [F3]Each RSU is eligible to vest on the third anniversary of the grant date of December 1, 2022.
- [F4]This represents the reporting person's PSUs that will be eligible for vesting based on achievement of absolute stock price compound annual growth rate goals ("Absolute CAGR PSUs") over a three-year performance period ending on November 30, 2025. The number of Absolute CAGR PSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001774478
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:11 PM ET
- Size
- 10.3 KB